Dexcom vs Edwards Lifesciences (DXCM vs EW)
Dexcom (DXCM) vs Edwards Lifesciences (EW) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.
Dexcom (DXCM) and Edwards Lifesciences (EW) compete in healthcare and pharma. Here are Dexcom and Edwards Lifesciences side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Dexcom or Edwards Lifesciences.
Dexcom vs Edwards Lifesciences: the figures
| Figure | Dexcom | Edwards Lifesciences |
|---|---|---|
| Share price | $88.48 (November 4, 2026) | $99.37 (November 4, 2026) |
| Market cap | $33.0 billion | $57.3 billion |
| P/E (TTM) | 34.8x | 59.1x |
| Forward P/E | 28.2x | 29.4x |
| Revenue growth (quarter) | +11.2% | +13.6% |
| Net margin (TTM) | 19.4% | 15.4% |
| Net debt / EBITDA | Net cash | Net cash |
| Dividend yield | 0.00% | 0.00% |
| Beta | 1.44 | 0.83 |
Dexcom and Edwards Lifesciences figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Dexcom or Edwards Lifesciences figure is not available, and we never estimate it.
3 key differences between Dexcom and Edwards Lifesciences
- Valuation: Edwards Lifesciences trades at 59.1x its annual earnings and Dexcom at 34.8x; the market pays more for each dollar of Edwards Lifesciences profit, usually because it expects more growth.
- Volatility: Dexcom stock moves more (beta 1.44) than Edwards Lifesciences (beta 0.83); the higher the beta, the more it amplifies market swings.
- Debt: Dexcom owes -0.3x its annual operating profit (EBITDA), while Edwards Lifesciences holds more cash than debt.
Dexcom or Edwards Lifesciences: which fits your profile
- If you want growth: Edwards Lifesciences is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
- If you prefer caution: Edwards Lifesciences has less debt relative to its profit, which usually gives more room in a bad year.
- If price is what matters most to you: Dexcom trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.
Neither Dexcom nor Edwards Lifesciences wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.
How Dexcom and Edwards Lifesciences make money
Dexcom (DXCM)
Dexcom makes continuous glucose monitors, small sensors worn on the skin that send blood sugar readings to a phone. Most revenue comes from disposable sensors that people with diabetes replace regularly, sold through distributors and pharmacies, and it also offers the over-the-counter Stelo. The United States is its largest market. Full Dexcom analysis.
Edwards Lifesciences (EW)
Edwards Lifesciences makes artificial heart valves. Its biggest business is transcatheter aortic valve replacement, or TAVR, with the Sapien family, and it also sells mitral and tricuspid repair and replacement devices such as Pascal and Evoque, plus surgical valves. Hospitals in the United States, Europe and Japan are its main customers. Full Edwards Lifesciences analysis.
Frequently asked questions: Dexcom vs Edwards Lifesciences
Is Dexcom or Edwards Lifesciences the better stock?
Choosing between Dexcom and Edwards Lifesciences depends on what you are looking for. Edwards Lifesciences is growing faster right now, and Dexcom trades on the lower P/E. Fintols does not tell you whether to buy Dexcom or Edwards Lifesciences: it shows you the differences so you can decide.
Which pays a higher dividend, Dexcom or Edwards Lifesciences?
Neither pays a dividend as of November 4, 2026: Dexcom and Edwards Lifesciences put what they earn into growth or other forms of shareholder return.
Which is more expensive, Dexcom or Edwards Lifesciences?
On P/E, Edwards Lifesciences (59.1x) is more expensive than Dexcom (34.8x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.
Can I own both Dexcom and Edwards Lifesciences?
Yes. Many people spread their money across several companies, such as Dexcom and Edwards Lifesciences, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Dexcom or Edwards Lifesciences.
More comparisons with Dexcom or Edwards Lifesciences
More companies like Dexcom and Edwards Lifesciences: healthcare and pharma stocks. Educational content about Dexcom and Edwards Lifesciences, not investment advice.